SlideShare a Scribd company logo
Measures – cumulative incidence
• Different methods for calculating
– Simple cumulative
– Actuarial
– Kaplan-Meier
– Density
Measures – cumulative incidence
• Subscript notation
– R(t0,tj) – risk of disease over the time interval t0
(baseline) to tj (time j)
– R(tj-1,tj) – risk of disease over the time interval tj-1
(time before time j) to tj (time j)
Measures – cumulative incidence
• Subscript notation
– N’0 – number at risk of disease at t0 (baseline)
– N’0j – number at risk of disease at the beginning of
interval j
Measures – cumulative incidence
• Subscript notation
– Ij – incident cases during the interval j
– Wj – withdrawals during the interval j
Measures – cumulative incidence
Simple cumulative method:
R(t0,tj) = CI(t0,tj) = I
N'0
• Risk calculated across entire study period assuming all
study participants followed for the entire study period, or
until disease onset
– Assumes no death from competing causes, no withdrawals
• Only appropriate for short time frame
Measures – cumulative incidence
Simple cumulative method:
• Example: incidence of a foodborne illness if all those
potentially exposed are identified
Measures – cumulative incidence
Actuarial method:
R(tj-1, tj) = CI(tj-1, tj)
= Ij
N'0j - Wj/2
• Risk calculated accounting for fact that some
observations will be censored or will withdraw
• Assume withdrawals occur halfway through each
observation period on average
• Can be calculated over an entire study period
– R(t0,tj) = CI(t0, tj) = I/(N’0-W/2)
• Typically calculated over shorter time frames and risks
accumulated
Measures – cumulative incidence
Modification of Szklo Fig. 2-2 – participants observed every 2 months (vs 1)
• Where to start – set up table with time intervals
• Fill incident disease cases and withdrawals into appropriate
intervals
• Fill in population at risk
Measures – cumulative incidence
Actuarial Method
• Calculate interval risk
• R(tj-1, tj) = Ij/(N’0j-(Wj/2))
• R(0,2)=1/(10-(1/2)) = 0.11
Measures – cumulative incidence
Actuarial Method
• Calculate interval survival
• next step: S(tj-1,tj) = 1-R(tj-1,tj)
Measures – cumulative incidence
Actuarial Method
• Calculate cumulative risk – example of time 0 to 10
• R(t0, tj) = 1 - Π (1 – R(tj-1,tj)) = 1 - Π (S(tj-1,tj))
• R(0, 10) = 1 – (0.89 x 0.88 x 1.0 x 1.0 x 0.85) = 0.34
Measures – cumulative incidence
Actuarial Method
• Calculate cumulative survival
• S(t0,tj) = 1-R(t0,tj)
Measures – cumulative incidence
Actuarial Method
• Intuition for why R(t0, tj) = 1 - Π (Sj) using
conditional probabilities
• Example of 5 time intervals:
– Π (Sj) = P(S1)*P(S2|S1)*P(S3|S2)*P(S4|S3)*P(S5|S4)
= P(S5)
– Multiply first two terms: P(S2|S1)*P(S1) = P(S2)
– Multiplying conditional probabilities gives you
unconditional probability of surviving up to any given
time point
– the value (1 - survival) up to (or at) a given time point
is then the probability of not surviving up to that time
point
Measures – cumulative incidence
Measures – cumulative incidence
• Exercise for home (discuss in lab)
– Study population observed monthly for 6 months
– Calculate the cumulative incidence of disease from
month 0 to 6
Measures – cumulative incidence
Kaplan-Meier method:
Ij
Nj
Rj = CIj =
• Risk calculated at the time each disease event occurs
– Accounts for withdrawals in that Nj only includes those at risk at
each time j point
– Result differs from actuarial approach in that the time of a
withdrawal (in Kaplan-Meier analysis) coincides with time of an
incident disease
• Risks at each onset time j accumulated
• Where to start – set up table with times of incident cases
• Fill in population at risk – anyone who has withdrawn by a time j is
no longer at risk at that time
Measures – cumulative incidence
Kaplan-Meier Method
JC: discuss withdrawals
• Calculate risk at time j
• Rj = Ij/Nj
• R2=1/10 = 0.10
• R4=1/8 = 0.125
Measures – cumulative incidence
Kaplan-Meier Method
• Survival calculated as in actuarial method
• Cumulative risk calculated as in actuarial method
– R(t0, tj) = 1 - Π (1 – Rj) = 1 - Π (Sj)
• Cumulative survival calculated as in actuarial method
Measures – cumulative incidence
Kaplan-Meier Method
JC: mention product-limit
Measures – cumulative incidence
Density method:
R (-ID*Δt)
(t0,t) = 1 – S(t0,t) = 1- e
• Depends on functional relationship between a risk and a
rate
• Can be calculated over an entire study period if the rate
is constant
• Can also be calculated over shorter time frames and
risks accumulated
JC: Mention Elandt-Johnson article
Where to start – set up table with time intervals
• Fill incident disease cases, withdrawals and population at risk by
interval
• Calculate person time (for example used formula PTj=(N’0j-(Wj/2))
Δtj)
• Calculate IDj = Ij/PTj
Measures – cumulative incidence
Density Method
R(t0,t) = 1 – S(t0,t) = 1- e (-ID*Δt)
• Calculate interval risk
•
• R(0,2) = 1-e(-0.05*2)
= 0.10
Measures – cumulative incidence
Density Method
R(t0,t) = 1- e
• Calculate cumulative risk – example of time 0 to 10
• Accumulate interval risks as in actuarial method
• Or calculate cumulative risk directly
• (-∑ID*Δt)
• R(0,10) = 1-e(-(0.05*2+0.06*2+0*2+0*2+0.08*2)
= 0.32
Measures – cumulative incidence
Density Method
• Cumulative survival calculated as in actuarial method
Measures – cumulative incidence
Density Method
Measures – cumulative incidence
Cumulative incidence
• Summary of methods for calculating and basis of
choosing
– Simple cumulative – complete follow-up
– Actuarial – incomplete follow-up
– Kaplan-Meier – incomplete follow-up
– Density – converting incidence density to cumulative incidence
Choosing among the CI methods
• Do you only have rate data? Generally you will choose incidence density.
•
• Do you have zero withdrawals and a short time period of interest? If so,
simple CI usually OK.
•
• Do you have fairly exact data on time of incidence and time of withdrawal?
If so, density preferable.
•
• Do you have fairly exact data on time of incidence but only interval data on
withdrawals? If so, KM most common choice; actuarial or density may not
be too different depending on withdrawal timing.
•
• Do you have interval data for incidence and withdrawal? If so, actuarial
most common choice, KM and density may not be too different depending
on withdrawal timing.
• Assumptions
– Uniformity of events and losses within each interval
(the W/2)
– Independence between censoring and survival –
otherwise biased/not accurate (also true for ID)
– Lack of secular trends
Measures – cumulative incidence
Epidemiologic measures
Szklo Exhibit 2-1

More Related Content

What's hot

Statistical Distributions
Statistical DistributionsStatistical Distributions
Statistical Distributions
Venkata Reddy Konasani
 
Inferential statistics.ppt
Inferential statistics.pptInferential statistics.ppt
Inferential statistics.ppt
Nursing Path
 
Survival analysis & Kaplan Meire
Survival analysis & Kaplan MeireSurvival analysis & Kaplan Meire
Survival analysis & Kaplan Meire
Dr Athar Khan
 
Sample size calculation
Sample  size calculationSample  size calculation
Sample size calculation
Swati Singh
 
Scales of Measurement - Statistics
Scales of Measurement - StatisticsScales of Measurement - Statistics
Scales of Measurement - Statistics
Thiyagu K
 
Descriptive statistics
Descriptive statisticsDescriptive statistics
Descriptive statistics
Hiba Armouche
 
Survival analysis
Survival analysisSurvival analysis
Survival analysis
Har Jindal
 
Descriptive and Analytical Epidemiology
Descriptive and Analytical Epidemiology Descriptive and Analytical Epidemiology
Descriptive and Analytical Epidemiology
coolboy101pk
 
Biostatistics : Types of Variable
Biostatistics : Types of VariableBiostatistics : Types of Variable
Biostatistics : Types of Variable
Tarekk Alazabee
 
Burden of Disease Analysis
Burden of Disease AnalysisBurden of Disease Analysis
Burden of Disease Analysis
sourav goswami
 
Survival analysis
Survival analysisSurvival analysis
Survival analysis
Sanjaya Sahoo
 
Epidemiolgy and biostatistics notes
Epidemiolgy and biostatistics notesEpidemiolgy and biostatistics notes
Epidemiolgy and biostatistics notes
Charles Ntwale
 
Case control study
Case control studyCase control study
Case control study
swati shikha
 
Measures Of Association
Measures Of AssociationMeasures Of Association
Measures Of Association
ganesh kumar
 
Ecological study
Ecological studyEcological study
Ecological study
Nik Ronaidi
 
DESCRIPTIVE EPIDEMIOLOGY
DESCRIPTIVE EPIDEMIOLOGYDESCRIPTIVE EPIDEMIOLOGY
DESCRIPTIVE EPIDEMIOLOGY
Shyam Chaturvedi
 
Fishers test
Fishers testFishers test
Fishers test
Princy Francis M
 
Statistics in medical research
Statistics in medical researchStatistics in medical research
Statistics in medical research
Ashok Kulkarni
 
Descriptive Statistics
Descriptive StatisticsDescriptive Statistics
Descriptive Statistics
Neny Isharyanti
 
Parametric & non parametric
Parametric & non parametricParametric & non parametric
Parametric & non parametric
ANCYBS
 

What's hot (20)

Statistical Distributions
Statistical DistributionsStatistical Distributions
Statistical Distributions
 
Inferential statistics.ppt
Inferential statistics.pptInferential statistics.ppt
Inferential statistics.ppt
 
Survival analysis & Kaplan Meire
Survival analysis & Kaplan MeireSurvival analysis & Kaplan Meire
Survival analysis & Kaplan Meire
 
Sample size calculation
Sample  size calculationSample  size calculation
Sample size calculation
 
Scales of Measurement - Statistics
Scales of Measurement - StatisticsScales of Measurement - Statistics
Scales of Measurement - Statistics
 
Descriptive statistics
Descriptive statisticsDescriptive statistics
Descriptive statistics
 
Survival analysis
Survival analysisSurvival analysis
Survival analysis
 
Descriptive and Analytical Epidemiology
Descriptive and Analytical Epidemiology Descriptive and Analytical Epidemiology
Descriptive and Analytical Epidemiology
 
Biostatistics : Types of Variable
Biostatistics : Types of VariableBiostatistics : Types of Variable
Biostatistics : Types of Variable
 
Burden of Disease Analysis
Burden of Disease AnalysisBurden of Disease Analysis
Burden of Disease Analysis
 
Survival analysis
Survival analysisSurvival analysis
Survival analysis
 
Epidemiolgy and biostatistics notes
Epidemiolgy and biostatistics notesEpidemiolgy and biostatistics notes
Epidemiolgy and biostatistics notes
 
Case control study
Case control studyCase control study
Case control study
 
Measures Of Association
Measures Of AssociationMeasures Of Association
Measures Of Association
 
Ecological study
Ecological studyEcological study
Ecological study
 
DESCRIPTIVE EPIDEMIOLOGY
DESCRIPTIVE EPIDEMIOLOGYDESCRIPTIVE EPIDEMIOLOGY
DESCRIPTIVE EPIDEMIOLOGY
 
Fishers test
Fishers testFishers test
Fishers test
 
Statistics in medical research
Statistics in medical researchStatistics in medical research
Statistics in medical research
 
Descriptive Statistics
Descriptive StatisticsDescriptive Statistics
Descriptive Statistics
 
Parametric & non parametric
Parametric & non parametricParametric & non parametric
Parametric & non parametric
 

Similar to 1.5.5 measures – cumulative incidence

Ph250b.14 measures of disease part 2 fri sep 5 2014
Ph250b.14 measures of disease part 2  fri sep 5 2014 Ph250b.14 measures of disease part 2  fri sep 5 2014
Ph250b.14 measures of disease part 2 fri sep 5 2014
A M
 
1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density
A M
 
Simulation Study for Extended AUC In Disease Risk Prediction in survival anal...
Simulation Study for Extended AUC In Disease Risk Prediction in survival anal...Simulation Study for Extended AUC In Disease Risk Prediction in survival anal...
Simulation Study for Extended AUC In Disease Risk Prediction in survival anal...
Gang Cui
 
Sample size estimation
Sample size estimationSample size estimation
Sample size estimation
Nabil Al-Rabeei
 
Biostat_Chapter6_Part3.pdf Bio Statistics
Biostat_Chapter6_Part3.pdf Bio StatisticsBiostat_Chapter6_Part3.pdf Bio Statistics
Biostat_Chapter6_Part3.pdf Bio Statistics
ArwaAbdelHamid1
 
ChandanChakrabarty_1.pdf
ChandanChakrabarty_1.pdfChandanChakrabarty_1.pdf
ChandanChakrabarty_1.pdf
Dikshathawait
 
1.5.6 measures – relations among measures
1.5.6 measures – relations among measures1.5.6 measures – relations among measures
1.5.6 measures – relations among measures
A M
 
Survival Analysis
Survival AnalysisSurvival Analysis
Survival Analysis
SMAliKazemi
 
Theory of errors
Theory of errors Theory of errors
Theory of errors
kamariya keyur
 
MD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and StatisticsMD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and Statistics
Bernard Deepal W. Jayamanne
 
Dr.Dinesh-BIOSTAT-Tests-of-significance-1-min.pdf
Dr.Dinesh-BIOSTAT-Tests-of-significance-1-min.pdfDr.Dinesh-BIOSTAT-Tests-of-significance-1-min.pdf
Dr.Dinesh-BIOSTAT-Tests-of-significance-1-min.pdf
HassanMohyUdDin2
 
Ct lecture 8. comparing two groups categorical data
Ct lecture 8. comparing two groups   categorical dataCt lecture 8. comparing two groups   categorical data
Ct lecture 8. comparing two groups categorical data
Hau Pham
 
Survival Analysis Lecture.ppt
Survival Analysis Lecture.pptSurvival Analysis Lecture.ppt
Survival Analysis Lecture.ppt
habtamu biazin
 
Chapter 11Survival AnalysisLearning Objectives.docx
Chapter 11Survival AnalysisLearning Objectives.docxChapter 11Survival AnalysisLearning Objectives.docx
Chapter 11Survival AnalysisLearning Objectives.docx
keturahhazelhurst
 
Proportions and Confidence Intervals in Biostatistics
Proportions and Confidence Intervals in BiostatisticsProportions and Confidence Intervals in Biostatistics
Proportions and Confidence Intervals in Biostatistics
HelpWithAssignment.com
 
2014 lab slides measures of disease_final (4)
2014 lab slides measures of disease_final (4)2014 lab slides measures of disease_final (4)
2014 lab slides measures of disease_final (4)
A M
 
1.D.1.DiseFreq.ppt
1.D.1.DiseFreq.ppt1.D.1.DiseFreq.ppt
1.D.1.DiseFreq.ppt
SujitKumarBehera16
 
Statisticslectures 140625114154-phpapp01
Statisticslectures 140625114154-phpapp01Statisticslectures 140625114154-phpapp01
Statisticslectures 140625114154-phpapp01
Cleophas Rwemera
 
Statistics lectures
Statistics lecturesStatistics lectures
Statistics lectures
vanessawhitehawk
 
UNIT 2.pptx
UNIT 2.pptxUNIT 2.pptx
UNIT 2.pptx
mrunmayee20
 

Similar to 1.5.5 measures – cumulative incidence (20)

Ph250b.14 measures of disease part 2 fri sep 5 2014
Ph250b.14 measures of disease part 2  fri sep 5 2014 Ph250b.14 measures of disease part 2  fri sep 5 2014
Ph250b.14 measures of disease part 2 fri sep 5 2014
 
1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density1.5.4 measures incidence+incidence density
1.5.4 measures incidence+incidence density
 
Simulation Study for Extended AUC In Disease Risk Prediction in survival anal...
Simulation Study for Extended AUC In Disease Risk Prediction in survival anal...Simulation Study for Extended AUC In Disease Risk Prediction in survival anal...
Simulation Study for Extended AUC In Disease Risk Prediction in survival anal...
 
Sample size estimation
Sample size estimationSample size estimation
Sample size estimation
 
Biostat_Chapter6_Part3.pdf Bio Statistics
Biostat_Chapter6_Part3.pdf Bio StatisticsBiostat_Chapter6_Part3.pdf Bio Statistics
Biostat_Chapter6_Part3.pdf Bio Statistics
 
ChandanChakrabarty_1.pdf
ChandanChakrabarty_1.pdfChandanChakrabarty_1.pdf
ChandanChakrabarty_1.pdf
 
1.5.6 measures – relations among measures
1.5.6 measures – relations among measures1.5.6 measures – relations among measures
1.5.6 measures – relations among measures
 
Survival Analysis
Survival AnalysisSurvival Analysis
Survival Analysis
 
Theory of errors
Theory of errors Theory of errors
Theory of errors
 
MD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and StatisticsMD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and Statistics
 
Dr.Dinesh-BIOSTAT-Tests-of-significance-1-min.pdf
Dr.Dinesh-BIOSTAT-Tests-of-significance-1-min.pdfDr.Dinesh-BIOSTAT-Tests-of-significance-1-min.pdf
Dr.Dinesh-BIOSTAT-Tests-of-significance-1-min.pdf
 
Ct lecture 8. comparing two groups categorical data
Ct lecture 8. comparing two groups   categorical dataCt lecture 8. comparing two groups   categorical data
Ct lecture 8. comparing two groups categorical data
 
Survival Analysis Lecture.ppt
Survival Analysis Lecture.pptSurvival Analysis Lecture.ppt
Survival Analysis Lecture.ppt
 
Chapter 11Survival AnalysisLearning Objectives.docx
Chapter 11Survival AnalysisLearning Objectives.docxChapter 11Survival AnalysisLearning Objectives.docx
Chapter 11Survival AnalysisLearning Objectives.docx
 
Proportions and Confidence Intervals in Biostatistics
Proportions and Confidence Intervals in BiostatisticsProportions and Confidence Intervals in Biostatistics
Proportions and Confidence Intervals in Biostatistics
 
2014 lab slides measures of disease_final (4)
2014 lab slides measures of disease_final (4)2014 lab slides measures of disease_final (4)
2014 lab slides measures of disease_final (4)
 
1.D.1.DiseFreq.ppt
1.D.1.DiseFreq.ppt1.D.1.DiseFreq.ppt
1.D.1.DiseFreq.ppt
 
Statisticslectures 140625114154-phpapp01
Statisticslectures 140625114154-phpapp01Statisticslectures 140625114154-phpapp01
Statisticslectures 140625114154-phpapp01
 
Statistics lectures
Statistics lecturesStatistics lectures
Statistics lectures
 
UNIT 2.pptx
UNIT 2.pptxUNIT 2.pptx
UNIT 2.pptx
 

More from A M

Transparency7
Transparency7Transparency7
Transparency7
A M
 
Transparency6
Transparency6Transparency6
Transparency6
A M
 
Transparency5
Transparency5Transparency5
Transparency5
A M
 
Transparency4
Transparency4Transparency4
Transparency4
A M
 
Transparency3
Transparency3Transparency3
Transparency3
A M
 
Transparency2
Transparency2Transparency2
Transparency2
A M
 
Transparency1
Transparency1Transparency1
Transparency1
A M
 
5.3.5 causal inference in research
5.3.5 causal inference in research5.3.5 causal inference in research
5.3.5 causal inference in research
A M
 
5.3.4 reporting em
5.3.4 reporting em5.3.4 reporting em
5.3.4 reporting em
A M
 
5.3.3 potential outcomes em
5.3.3 potential outcomes em5.3.3 potential outcomes em
5.3.3 potential outcomes em
A M
 
5.3.2 sufficient cause em
5.3.2 sufficient cause em5.3.2 sufficient cause em
5.3.2 sufficient cause em
A M
 
5.3.1 causal em
5.3.1 causal em5.3.1 causal em
5.3.1 causal em
A M
 
5.2.3 dags for selection bias
5.2.3 dags for selection bias5.2.3 dags for selection bias
5.2.3 dags for selection bias
A M
 
5.2.2 dags for confounding
5.2.2 dags for confounding5.2.2 dags for confounding
5.2.2 dags for confounding
A M
 
5.1.3 hills criteria
5.1.3 hills criteria5.1.3 hills criteria
5.1.3 hills criteria
A M
 
5.1.2 counterfactual framework
5.1.2 counterfactual framework5.1.2 counterfactual framework
5.1.2 counterfactual framework
A M
 
5.1.1 sufficient component cause model
5.1.1 sufficient component cause model5.1.1 sufficient component cause model
5.1.1 sufficient component cause model
A M
 
5.2.1 dags
5.2.1 dags5.2.1 dags
5.2.1 dags
A M
 
4.4. effect modification
4.4. effect modification4.4. effect modification
4.4. effect modification
A M
 
4.5. logistic regression
4.5. logistic regression4.5. logistic regression
4.5. logistic regression
A M
 

More from A M (20)

Transparency7
Transparency7Transparency7
Transparency7
 
Transparency6
Transparency6Transparency6
Transparency6
 
Transparency5
Transparency5Transparency5
Transparency5
 
Transparency4
Transparency4Transparency4
Transparency4
 
Transparency3
Transparency3Transparency3
Transparency3
 
Transparency2
Transparency2Transparency2
Transparency2
 
Transparency1
Transparency1Transparency1
Transparency1
 
5.3.5 causal inference in research
5.3.5 causal inference in research5.3.5 causal inference in research
5.3.5 causal inference in research
 
5.3.4 reporting em
5.3.4 reporting em5.3.4 reporting em
5.3.4 reporting em
 
5.3.3 potential outcomes em
5.3.3 potential outcomes em5.3.3 potential outcomes em
5.3.3 potential outcomes em
 
5.3.2 sufficient cause em
5.3.2 sufficient cause em5.3.2 sufficient cause em
5.3.2 sufficient cause em
 
5.3.1 causal em
5.3.1 causal em5.3.1 causal em
5.3.1 causal em
 
5.2.3 dags for selection bias
5.2.3 dags for selection bias5.2.3 dags for selection bias
5.2.3 dags for selection bias
 
5.2.2 dags for confounding
5.2.2 dags for confounding5.2.2 dags for confounding
5.2.2 dags for confounding
 
5.1.3 hills criteria
5.1.3 hills criteria5.1.3 hills criteria
5.1.3 hills criteria
 
5.1.2 counterfactual framework
5.1.2 counterfactual framework5.1.2 counterfactual framework
5.1.2 counterfactual framework
 
5.1.1 sufficient component cause model
5.1.1 sufficient component cause model5.1.1 sufficient component cause model
5.1.1 sufficient component cause model
 
5.2.1 dags
5.2.1 dags5.2.1 dags
5.2.1 dags
 
4.4. effect modification
4.4. effect modification4.4. effect modification
4.4. effect modification
 
4.5. logistic regression
4.5. logistic regression4.5. logistic regression
4.5. logistic regression
 

Recently uploaded

Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
Gokuldas Hospital
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
DrGirishJHoogar
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
rightmanforbloodline
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Kunj Vihari
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
Gokuldas Hospital
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 

Recently uploaded (20)

Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 

1.5.5 measures – cumulative incidence

  • 1. Measures – cumulative incidence • Different methods for calculating – Simple cumulative – Actuarial – Kaplan-Meier – Density
  • 2. Measures – cumulative incidence • Subscript notation – R(t0,tj) – risk of disease over the time interval t0 (baseline) to tj (time j) – R(tj-1,tj) – risk of disease over the time interval tj-1 (time before time j) to tj (time j)
  • 3. Measures – cumulative incidence • Subscript notation – N’0 – number at risk of disease at t0 (baseline) – N’0j – number at risk of disease at the beginning of interval j
  • 4. Measures – cumulative incidence • Subscript notation – Ij – incident cases during the interval j – Wj – withdrawals during the interval j
  • 5. Measures – cumulative incidence Simple cumulative method: R(t0,tj) = CI(t0,tj) = I N'0 • Risk calculated across entire study period assuming all study participants followed for the entire study period, or until disease onset – Assumes no death from competing causes, no withdrawals • Only appropriate for short time frame
  • 6. Measures – cumulative incidence Simple cumulative method: • Example: incidence of a foodborne illness if all those potentially exposed are identified
  • 7. Measures – cumulative incidence Actuarial method: R(tj-1, tj) = CI(tj-1, tj) = Ij N'0j - Wj/2 • Risk calculated accounting for fact that some observations will be censored or will withdraw • Assume withdrawals occur halfway through each observation period on average • Can be calculated over an entire study period – R(t0,tj) = CI(t0, tj) = I/(N’0-W/2) • Typically calculated over shorter time frames and risks accumulated
  • 8. Measures – cumulative incidence Modification of Szklo Fig. 2-2 – participants observed every 2 months (vs 1)
  • 9. • Where to start – set up table with time intervals • Fill incident disease cases and withdrawals into appropriate intervals • Fill in population at risk Measures – cumulative incidence Actuarial Method
  • 10. • Calculate interval risk • R(tj-1, tj) = Ij/(N’0j-(Wj/2)) • R(0,2)=1/(10-(1/2)) = 0.11 Measures – cumulative incidence Actuarial Method
  • 11. • Calculate interval survival • next step: S(tj-1,tj) = 1-R(tj-1,tj) Measures – cumulative incidence Actuarial Method
  • 12. • Calculate cumulative risk – example of time 0 to 10 • R(t0, tj) = 1 - Π (1 – R(tj-1,tj)) = 1 - Π (S(tj-1,tj)) • R(0, 10) = 1 – (0.89 x 0.88 x 1.0 x 1.0 x 0.85) = 0.34 Measures – cumulative incidence Actuarial Method
  • 13. • Calculate cumulative survival • S(t0,tj) = 1-R(t0,tj) Measures – cumulative incidence Actuarial Method
  • 14. • Intuition for why R(t0, tj) = 1 - Π (Sj) using conditional probabilities • Example of 5 time intervals: – Π (Sj) = P(S1)*P(S2|S1)*P(S3|S2)*P(S4|S3)*P(S5|S4) = P(S5) – Multiply first two terms: P(S2|S1)*P(S1) = P(S2) – Multiplying conditional probabilities gives you unconditional probability of surviving up to any given time point – the value (1 - survival) up to (or at) a given time point is then the probability of not surviving up to that time point Measures – cumulative incidence
  • 15. Measures – cumulative incidence • Exercise for home (discuss in lab) – Study population observed monthly for 6 months – Calculate the cumulative incidence of disease from month 0 to 6
  • 16. Measures – cumulative incidence Kaplan-Meier method: Ij Nj Rj = CIj = • Risk calculated at the time each disease event occurs – Accounts for withdrawals in that Nj only includes those at risk at each time j point – Result differs from actuarial approach in that the time of a withdrawal (in Kaplan-Meier analysis) coincides with time of an incident disease • Risks at each onset time j accumulated
  • 17. • Where to start – set up table with times of incident cases • Fill in population at risk – anyone who has withdrawn by a time j is no longer at risk at that time Measures – cumulative incidence Kaplan-Meier Method JC: discuss withdrawals
  • 18. • Calculate risk at time j • Rj = Ij/Nj • R2=1/10 = 0.10 • R4=1/8 = 0.125 Measures – cumulative incidence Kaplan-Meier Method
  • 19. • Survival calculated as in actuarial method • Cumulative risk calculated as in actuarial method – R(t0, tj) = 1 - Π (1 – Rj) = 1 - Π (Sj) • Cumulative survival calculated as in actuarial method Measures – cumulative incidence Kaplan-Meier Method JC: mention product-limit
  • 20. Measures – cumulative incidence Density method: R (-ID*Δt) (t0,t) = 1 – S(t0,t) = 1- e • Depends on functional relationship between a risk and a rate • Can be calculated over an entire study period if the rate is constant • Can also be calculated over shorter time frames and risks accumulated JC: Mention Elandt-Johnson article
  • 21. Where to start – set up table with time intervals • Fill incident disease cases, withdrawals and population at risk by interval • Calculate person time (for example used formula PTj=(N’0j-(Wj/2)) Δtj) • Calculate IDj = Ij/PTj Measures – cumulative incidence Density Method
  • 22. R(t0,t) = 1 – S(t0,t) = 1- e (-ID*Δt) • Calculate interval risk • • R(0,2) = 1-e(-0.05*2) = 0.10 Measures – cumulative incidence Density Method
  • 23. R(t0,t) = 1- e • Calculate cumulative risk – example of time 0 to 10 • Accumulate interval risks as in actuarial method • Or calculate cumulative risk directly • (-∑ID*Δt) • R(0,10) = 1-e(-(0.05*2+0.06*2+0*2+0*2+0.08*2) = 0.32 Measures – cumulative incidence Density Method
  • 24. • Cumulative survival calculated as in actuarial method Measures – cumulative incidence Density Method
  • 25. Measures – cumulative incidence Cumulative incidence • Summary of methods for calculating and basis of choosing – Simple cumulative – complete follow-up – Actuarial – incomplete follow-up – Kaplan-Meier – incomplete follow-up – Density – converting incidence density to cumulative incidence
  • 26. Choosing among the CI methods • Do you only have rate data? Generally you will choose incidence density. • • Do you have zero withdrawals and a short time period of interest? If so, simple CI usually OK. • • Do you have fairly exact data on time of incidence and time of withdrawal? If so, density preferable. • • Do you have fairly exact data on time of incidence but only interval data on withdrawals? If so, KM most common choice; actuarial or density may not be too different depending on withdrawal timing. • • Do you have interval data for incidence and withdrawal? If so, actuarial most common choice, KM and density may not be too different depending on withdrawal timing.
  • 27. • Assumptions – Uniformity of events and losses within each interval (the W/2) – Independence between censoring and survival – otherwise biased/not accurate (also true for ID) – Lack of secular trends Measures – cumulative incidence